Rankings
▼
Calendar
MNKD Q3 2024 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$70M
+36.7% YoY
Gross Profit
$52M
74.3% margin
Operating Income
$13M
18.2% margin
Net Income
$12M
16.5% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
-3.2%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$8M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$464M
Total Liabilities
$674M
Stockholders' Equity
-$210M
Cash & Equivalents
$62M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$70M
$51M
+36.7%
Gross Profit
$52M
$37M
+40.7%
Operating Income
$13M
$5M
+150.3%
Net Income
$12M
$2M
+571.1%
Revenue Segments
Royalty
$27M
39%
License And Service
$23M
33%
Product
$20M
28%
← FY 2024
All Quarters
Q4 2024 →